Focal Epilepsy
Focal epilepsy is a type of epilepsy where seizures start in a specific area of the brain, leading to various symptoms depending on the affected region. It can sometimes be difficult to control with medication.
Refractory Focal Onset Epilepsy: BHV-7000 Safety Study
We are evaluating the safety and tolerability of BHV-7000 in adults with refractory focal onset epilepsy. This study aims to ensure the treatment is safe for those who have not found relief with other options.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female of childbearing potential and can you confirm a negative urine pregnancy test?
- Have you completed the double-blind phase of the prior study BHV7000-302 or BHV7000-303?
- Do you have any ongoing health issues that make it hard for you to follow study instructions?
- Do you have any medical conditions that could affect the study results, as judged by a doctor?
- Are you currently taking any medications that could interfere with the study?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bhv-7000
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Johannes Kepler University Linz
Universitätsklinik für Neurologie
Linz, Austria
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Salzburg, Austria
Noe LGA Gesundheit Region Mitte GmbH
Klinische Abteilung für Neurologie
Sankt Pölten, Austria
Sponsor: Biohaven Therapeutics Ltd.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.